|
2025
|
P/S
|
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparati... |
|
|
P/S
|
Research laboratory analysis services in the field of cancer drug research, development, and prod... |
|
|
P/S
|
Anti-cancer preparations; Antibiotics for human use; Pharmaceutical products for the prevention a... |
|
2024
|
Invention
|
Pharmaceutical forms of quinazoline erbb inhibitors. Disclosed are pharmaceutical forms of (S) -N... |
|
|
Invention
|
Pharmaceutical forms of quinazoline erbb inhibitors |
|
2023
|
Invention
|
Triazolopyrimidine compounds and their use in treating cancer.
The invention concerns compounds ... |
|
|
Invention
|
Erbb/btk inhibitors.
Disclosed are compounds inhibiting ErbBs (e.g., EGFR or Her 2), especially ... |
|
|
Invention
|
Egfr inhibitors and uses thereof. Disclosed herein are compounds or pharmaceutically acceptable s... |
|
|
P/S
|
Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical reagents ... |
|
|
Invention
|
Rock inhibitors and uses thereof.
Disclosed herein are compounds of Formula (I), and pharmaceuti... |
|
|
Invention
|
Rock inhibitors and uses thereof. Disclosed herein are compounds of Formula (I), and pharmaceutic... |
|
|
P/S
|
Laboratory analysis in the field of cancer drug research, development, and production; Medical an... |
|
|
P/S
|
Business research; Advisory services relating to business organisation and management; Advisory s... |
|
2022
|
Invention
|
Pyrazine compounds and uses thereof.
The present disclosure novel pyrazine compounds targeting a... |
|
|
Invention
|
Erbb/btk inhibitors. Disclosed are compounds inhibiting ErbBs (e.g., EGFR or Her 2), especially m... |
|
|
P/S
|
Anti-cancer preparations; biological preparations for the treatment of cancer; chemical reagents ... |
|
|
Invention
|
Erbb receptor inhibitors.
Disclosed are compounds inhibiting ErbBs (e.g. HER2), pharmaceutically... |
|
|
Invention
|
Novel pharmaceutical salts and polymorphic forms of an erbb and btk inhibitor.
Disclosed are nov... |
|
|
Invention
|
Novel pharmaceutical salts and polymorphic forms of an erbb and btk inhibitor. Disclosed are nove... |
|
|
P/S
|
Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; alumin... |
|
2021
|
Invention
|
Compounds and methods for inhibiting jak. Disclosed are compounds of formula (I), pharmaceutical ... |
|
|
Invention
|
Cyclopentane compounds. The present invention relates to cyclopentane compounds of Formula (I), p... |
|
|
Invention
|
Triazolopyrimidine compounds and their use in treating cancer. The invention concerns compounds o... |
|
2020
|
Invention
|
Btk inhibitors.
The invention relates to chemical compounds, or pharmaceutically acceptable salt... |
|
|
Invention
|
Btk inhibitors. Compounds of the formula (I), or pharmaceutically acceptable salts thereof, which... |
|
|
Invention
|
Novel anti-fgfr2b antibodies.
The present disclosure provides anti-FGFR2b antibodies or antigen-... |
|
|
Invention
|
Novel anti-fgfr2b antibodies.
Provided are anti-FGFR2b antibodies or antigen-binding fragments t... |
|
|
Invention
|
Novel anti-fgfr2b antibodies. The present disclosure provides anti-FGFR2b antibodies or antigen-b... |
|
|
Invention
|
Novel anti-fgfr2b antibodies. Provided are anti-FGFR2b antibodies or antigen-binding fragments th... |
|
|
P/S
|
Preparations for destroying noxious animals; antiseptics; bacterial culture mediums; bouillons fo... |
|
|
Invention
|
Erbb receptor inhibitors. Disclosed are quinazoline compounds inhibiting ErbBs (e.g. HER2), pharm... |
|
|
Invention
|
Pyrazine compounds and uses thereof. The present disclosure novel pyrazine compounds targeting ad... |
|
|
Invention
|
Triazolo-pyrimidine compounds and uses thereof. The present disclosure relates to novel triazolo-... |
|
|
Invention
|
Erbb receptor inhibitors. Disclosed are compounds inhibiting ErbBs (e.g. HER2), pharmaceutically ... |
|
|
Invention
|
Dna-dependent protein kinase inhibitor.
Disclosed herein are compounds of Formula (I), and pharm... |
|
|
Invention
|
Dna-dependent protein kinase inhibitor. Disclosed herein are compounds of Formula (I), and pharma... |
|
|
Invention
|
Jak1 selective kinase inhibitor.
Disclosed herein are compounds of Formula (I), and pharmaceutic... |
|
|
Invention
|
Jak1 selective kinase inhibitor. Disclosed herein are compounds of Formula (I), and pharmaceutica... |
|
2019
|
Invention
|
Selective estrogen receptor downregulators and uses thereof. The invention relates to novel tetra... |
|
|
Invention
|
Erbb receptor inhibitors. Disclosed are compounds inhibiting ErbBs (e. g. HER2), pharmaceutically... |
|
|
Invention
|
Erbb/btk inhibitors. Disclosed are compounds inhibiting ErbBs (e. g., EGFR or Her 2), especially ... |
